Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome

Tohoku Journal of Experimental Medicine

Volumn 227, Issue 2, 2012, Pages 119-128

  Fan, Rong ^a   Zhang, Lu Yao ^b   Wang, Hong ^c   Yang, Bo ^d   Han, Tao ^d   Zhao, Xiao Li ^a   Wang, Wei ^a   Wang, Xiao Qin ^a   Lin, Guo Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d Fudan Cinpathogen Clinical and Molecular Research Center   (China)

Author keywords

DNA methylation; Myelodysplastic syndromes; Prognosis; SOX7; Wnt

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR SOX7; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD CELL; BONE MARROW; CORRELATION ANALYSIS; CPG ISLAND; CYTOGENETICS; DNA METHYLATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; PROTEIN FUNCTION; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; SEQUENCE ANALYSIS; SOX7 GENE; TRANSCRIPTION REGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SOXF TRANSCRIPTION FACTORS; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84863826066     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.227.119     Document Type: Article

References (27)

1. Cermenati, S., Moleri, S., Cimbro, S., Corti, P., Del Giacco, L., Amodeo, R., Dejana, E., Koopman, P., Cotelli, F. & Beltrame, M. (2008) Sox18 and Sox7 play redundant roles in vascular development. Blood, 111, 2657-2666.
2. Du, Y., Fryzek, J., Sekeres, M.A. & Taioli, E. (2010) Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk. Res., 34, 1-5.
3. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodys-plastic syndromes. Blood, 89, 2079-2088.
4. Guo, L.H., Zhong, D.S., Lau, S., Liu, X.J., Dong, X.Y., Sun, X.D., Yang, V.W., Vertino, P.M., Moreno, C.S., Varma, V., Dong, J.T. & Zhou, W. (2008) Sox7 is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol. Cancer Res., 6, 1421-1430.
5. He, Y.L., Wang, Y.J., Li, P., Zhu, S.T., Wang, J.X. & Zhang, S.T. (2011) Identification of GPX3 Epigenetically Silenced by CpG Methylation in Human Esophageal Squamous Cell Carcinoma. Dig. Dis. Sci., 56, 681-688.
6. Heaney, M.L. & Golde, D.W. (1999) Myelodysplasia. N. Engl. J. Med., 340, 1649-1660.
7. Herpers, R., van de Kamp, E., Duckers, H.J. & Schulte-Merker, S. (2008) Redundant roles for Sox7 and Sox18 in arteriovenous specifcation in zebrafsh. Circ. Res., 102, 12-15.
8. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) Tumours of heamatopoietic and lympoid tissues. World Health Organization Classification of Tumours; IARC Publishing, France, pp. 61-73.
9. Kuendgen, A., Matsuda, A. & Germing, U. (2007) Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence? Leuk. Res., 31, 103-104.
10. Lehmann, U., Brakensiek, K. & Kreipe, H. (2004) Role of epigen-etic changes in hematological malignancies. Ann. Hematol., 83, 137-152.
11. Lv, D., Zhao, W., Dong, D., Qian, X.P., Zhang, Y., Tian, X.J. & Zhang, J. (2011) Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma. Eur. J. Cancer, 47, 2068-2076.
12. Mittelman, M., Oster, H.S., Hoffman, M. & Neumann, D. (2010) The lower risk MDS patient at risk of rapid progression. Leuk. Res., 34, 1551-1555.
13. Murakami, A., Shen, H.Q., Ishida, S. & Dickson, C. (2004) SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. J. Biol. Chem., 279, 28564-28573.
14. Nolte, F. & Hofmann, W.K. (2008) Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Ann. Hematol., 87, 777-795.
15. Pendeville, H., Winandy, M., Manfroid, I., Nivelles, O., Motte, P., Pasque, V., Peers, B., Struman, I., Martial, J.A. & Voz, M.L. (2008) Zebrafsh Sox7 and Sox18 function together to control arterial-venous identity. Dev. Biol., 317, 405-416.
16. Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz, L., Nusse, R. & Weissman, I.L. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
17. Sassa, M., Hayashi, Y., Watanabe, R., Kikumori, T., Imai, T., Kurebayashi, J., Kiuchi, T. & Murata, Y. (2011) Aberrant Promoter Methylation in Overexpression of CITED1 in Papillary Thyroid Cancer. Thyroid, 21, 511-517.
18. Simon, M., Grandage, V.L., Linch, D.C. & Khwaja, A. (2005) Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene, 24, 2410-2420.
19. Takash, W., Canizares, J., Bonneaud, N., Poulat, F., Mattei, M.G., Jay, P. & Berta, P. (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactiva-tion and interference with Wnt signalling. Nucleic. Acids. Res., 29, 4274-4283.
20. Tickenbrock, L., Hehn, S., Sargin, B., Choudhary, C., Baumer, N., Buerger, H., Schulte, B., Muller, O., Berdel, W.E., Muller-Tidow, C. & Serve, H. (2008) Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4. Int. J. Oncol., 33, 1215-1221.
21. Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Hellstrom-Lindberg, E., Tefferi, A. & Bloomfeld, C.D. (2009) The 2008 revision of the World Health Organization (WHO) classifca-tion of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 114, 937-951.
22. Wandt, H., Haferlach, T., Thiede, C. & Ehninger, G. (2010) WHO classification of myeloid neoplasms and leukemia. Blood, 115, 748-749; author reply 749-750.
23. Wang, Y., Krivtsov, A.V., Sinha, A.U., North, T.E., Goessling, W., Feng, Z., Zon, L.I. & Armstrong, S.A. (2010) The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science, 327, 1650-1653.
24. Wegner, M. (2010) All purpose Sox: The many roles of Sox proteins in gene expression. Int. J. Biochem. Cell. Biol., 42, 381-390.
25. Willert, K., Brown, J.D., Danenberg, E., Duncan, A.W., Weissman, I.L., Reya, T., Yates, J.R. & Nusse, R. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature, 423, 448-452.
26. Xueling, G.E. & Wang, X. (2010) Role of Wnt canonical pathway in hematological malignancies. J. Hematol. Oncol., 3.
27. Zhang, Y., Huang, S.Y., Dong, W., Li, L., Feng, Y.P., Pan, L.N., Han, Z.K., Wang, X.L., Ren, G.L., Su, D.M., Huang, B.Q. & Lu, J. (2009) SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett., 277, 29-37.